BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28799406)

  • 1. A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma.
    Franzoni A; Markova-Car E; Dević-Pavlić S; Jurišić D; Puppin C; Mio C; De Luca M; Petruz G; Damante G; Pavelić SK
    Exp Biol Med (Maywood); 2017 Sep; 242(15):1553-1558. PubMed ID: 28799406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CLOCK, ARNTL, and NPAS2 gene polymorphisms and seasonal variations in mood and behavior.
    Kim HI; Lee HJ; Cho CH; Kang SG; Yoon HK; Park YM; Lee SH; Moon JH; Song HM; Lee E; Kim L
    Chronobiol Int; 2015; 32(6):785-91. PubMed ID: 26134245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
    Zhu Y; Leaderer D; Guss C; Brown HN; Zhang Y; Boyle P; Stevens RG; Hoffman A; Qin Q; Han X; Zheng T
    Int J Cancer; 2007 Jan; 120(2):432-5. PubMed ID: 17096334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia.
    Jung JS; Lee HJ; Cho CH; Kang SG; Yoon HK; Park YM; Moon JH; Yang HJ; Song HM; Kim L
    Chronobiol Int; 2014 Aug; 31(7):838-44. PubMed ID: 24824748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-related orphan receptor γ directly regulates neuronal PAS domain protein 2 transcription in vivo.
    Takeda Y; Kang HS; Angers M; Jetten AM
    Nucleic Acids Res; 2011 Jun; 39(11):4769-82. PubMed ID: 21317191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression.
    Partonen T; Treutlein J; Alpman A; Frank J; Johansson C; Depner M; Aron L; Rietschel M; Wellek S; Soronen P; Paunio T; Koch A; Chen P; Lathrop M; Adolfsson R; Persson ML; Kasper S; Schalling M; Peltonen L; Schumann G
    Ann Med; 2007; 39(3):229-38. PubMed ID: 17457720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NAD(P)H and its derivatives on the DNA-binding activity of NPAS2, a mammalian circadian transcription factor.
    Yoshii K; Ishijima S; Sagami I
    Biochem Biophys Res Commun; 2013 Aug; 437(3):386-91. PubMed ID: 23831463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association of the NPAS2 gene Ala394Thr polymorphism (rs2305160:G>A) with risk of chronic lymphocytic leukemia.
    Rana S; Shahid A; Ullah H; Mahmood S
    Asian Pac J Cancer Prev; 2014; 15(17):7169-74. PubMed ID: 25227809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct repeat of E-box-like elements is required for cell-autonomous circadian rhythm of clock genes.
    Nakahata Y; Yoshida M; Takano A; Soma H; Yamamoto T; Yasuda A; Nakatsu T; Takumi T
    BMC Mol Biol; 2008 Jan; 9():1. PubMed ID: 18177499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopic and DNA-binding characterization of the isolated heme-bound basic helix-loop-helix-PAS-A domain of neuronal PAS protein 2 (NPAS2), a transcription activator protein associated with circadian rhythms.
    Mukaiyama Y; Uchida T; Sato E; Sasaki A; Sato Y; Igarashi J; Kurokawa H; Sagami I; Kitagawa T; Shimizu T
    FEBS J; 2006 Jun; 273(11):2528-39. PubMed ID: 16704425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.
    Yi CH; Zheng T; Leaderer D; Hoffman A; Zhu Y
    Cancer Lett; 2009 Nov; 284(2):149-56. PubMed ID: 19457610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.
    Hoffman AE; Zheng T; Ba Y; Zhu Y
    Mol Cancer Res; 2008 Sep; 6(9):1461-8. PubMed ID: 18819933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association study of circadian genes with seasonal pattern in bipolar disorders.
    Geoffroy PA; Lajnef M; Bellivier F; Jamain S; Gard S; Kahn JP; Henry C; Leboyer M; Etain B
    Sci Rep; 2015 May; 5():10232. PubMed ID: 25989161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
    Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
    Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
    Zhu Y; Stevens RG; Leaderer D; Hoffman A; Holford T; Zhang Y; Brown HN; Zheng T
    Breast Cancer Res Treat; 2008 Feb; 107(3):421-5. PubMed ID: 17453337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific disruption of rhythmic expression of Dec1 and Dec2 in clock mutant mice.
    Noshiro M; Furukawa M; Honma S; Kawamoto T; Hamada T; Honma K; Kato Y
    J Biol Rhythms; 2005 Oct; 20(5):404-18. PubMed ID: 16267380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.
    Smith AK; Fang H; Whistler T; Unger ER; Rajeevan MS
    Neuropsychobiology; 2011; 64(4):183-94. PubMed ID: 21912186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals.
    Kaasik K; Lee CC
    Nature; 2004 Jul; 430(6998):467-71. PubMed ID: 15269772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
    Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the AHR gene proximal promoter GGGGC-repeat polymorphism in lung, breast, and colon cancer.
    Spink BC; Bloom MS; Wu S; Sell S; Schneider E; Ding X; Spink DC
    Toxicol Appl Pharmacol; 2015 Jan; 282(1):30-41. PubMed ID: 25447411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.